Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis - 14/12/17
, Jonathan Lavian, BA, Gloria Lin, MS, Andrew Strunk, MA, Allireza Alloo, MDAbstract |
Background |
The true incidence of hidradenitis suppurativa (HS) is unknown.
Objective |
To determine standardized incidence estimates for HS in the United States.
Methods |
We used a retrospective cohort analysis, including incident HS cases identified using electronic health records data for a demographically heterogeneous population-based sample of >48 million unique patients across all 4 census regions. We calculated standardized 1- and 10-year cumulative incidences for the overall population and for sex-, age-, and race-specific groups.
Results |
There were 5410 new HS diagnoses over a 1-year period, with an incidence of 11.4 (95% confidence interval [CI], 11.1-11.8) cases per 100,000 population. One-year incidence in women was 16.1 (95% CI, 15.5-16.6) per 100,000, more than twice that of men [6.8 (95% CI, 6.5-7.2) per 100,000; P < .0001]. Age group–specific incidence was highest among patients 18 to 29 years of age [22.0 (95% CI, 21.0-23.2) per 100,000]. Incidence among African Americans [30.6 (95% CI, 29.1-32.2) per 100,000] was >2.5 times that of whites [11.7 (95% CI, 11.3-12.2) per 100,000; P < .0001]. The average annual overall incidence over 10 years was 8.6 (95% CI, 8.6-8.7) per 100,000 population.
Limitations |
The use of deidentified claims prevented validation for a larger case subset.
Conclusion |
HS incidence has increased over the past decade and disproportionately involves women, young adults, and African Americans.
Le texte complet de cet article est disponible en PDF.Key words : African American, cumulative, epidemiology, hidradenitis suppurativa, incidence
Plan
| Mr Lavian and Ms Lin contributed equally to the investigation and the article. |
|
| Funding sources: None. |
|
| Dr Garg has served as an advisor for AbbVie and received honoraria. |
|
| Reprints not available from the authors. |
Vol 77 - N° 1
P. 118-122 - juillet 2017 Retour au numéro
Article précédent
- Evidence-based recommendations for the management of acne fulminans and its variants
- Tanya Greywal, Andrea L. Zaenglein, Hilary E. Baldwin, Neal Bhatia, Karen A. Chernoff, James Q. Del Rosso, Lawrence F. Eichenfield, Marc H. Levin, James J. Leyden, Diane M. Thiboutot, Guy F. Webster, Sheila Fallon Friedlander
- The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients
- Christian Posch, Babak Monshi, Tamara Quint, Igor Vujic, Nikolaus Lilgenau, Klemens Rappersberger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?